Lovenjoel, Belgium

Erik Desire Alice De Clercq

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 3 EPO patents. Top assignee: Other. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erik Desire Alice De Clercq. Retrieved from https://idiyas.com/inventor/erik-desire-alice-de-clercq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 111(Granted Patents)


Company Filing History:

goldMedal1 out of 834,659 
Other
 patents

Years Active: 2003

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Erik Desire Alice De Clercq

Introduction

Erik Desire Alice De Clercq is a notable inventor based in Lovenjoel, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiretroviral medications. His work focuses on creating effective treatments for viral infections, showcasing his dedication to improving public health.

Latest Patents

Erik holds 1 patent for his invention titled "Antiretroviral enantiomeric nucleotide analogs." This patent represents a crucial advancement in the fight against viral diseases, providing new avenues for treatment options.

Career Highlights

Throughout his career, Erik has demonstrated a strong commitment to research and innovation. His work has not only contributed to scientific knowledge but has also paved the way for practical applications in medicine. His expertise in nucleotide analogs has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Erik has collaborated with esteemed colleagues such as Antonin Holy and Hana Dvorakova. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Erik Desire Alice De Clercq's contributions to the field of pharmaceuticals through his innovative patent work exemplify the importance of research in developing effective treatments. His dedication to advancing medical science continues to inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…